← All trials
NCT05682911
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2018
- Primary completion
- Jun 2, 2018
- Completion date
- Jun 30, 2018
- First posted
- Jan 12, 2023
- Last posted
- Jan 12, 2023
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Jinnah Sindh Medical UniversityLead sponsor
- Jinnah Sindh Medical UniversityReponsible party - principal investigator
- Jinnah Sindh Medical UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.